AI Buyer Insights:

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Helvetia Biopharma Data, Technology Stack, and Enterprise Applications
ERP Financial Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft Dynamics 365 for Finance and Operations ERP Financial ERP Financial Management n/a 2025 2025
EPM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
FloQast Legacy FloQast Accounting Automation Platform Financial Consolidation and Close EPM n/a 2025 2025
In 2025, Helvetia Biopharma implemented FloQast Accounting Automation Platform to centralize Financial Consolidation and Close capabilities and to strengthen controls ahead of its NASDAQ listing and SOX 404(b) compliance requirements. The initiative targeted the finance organization of a 150 person Swiss biopharmaceutical company, focusing on a 10 person accounting team operating across five legal entities and integrating with ERP Microsoft Dynamics 365 F&O. The implementation configured FloQast Accounting Automation Platform to manage month end close activities, link tasks directly to control documentation, and provide governance risk and control workflows that embed control testing and evidence capture into routine close processes. Key functional capabilities implemented included close management and task orchestration, control mapping between close activities and GRC artifacts, auditor access to documentation, and structured risk assessment and control testing workflows. Deployment architecture emphasized a cloud hosted close management layer integrated with Microsoft Dynamics 365 F&O for transactional and balance reconciliation inputs, while secure auditor access and centralized evidence storage supported audit readiness. The program was executed with technical and advisory support from FloQast and global advisory firm CFGI, completed in under two months with minimal disruption and coordinated across the companys five entities. Governance changes shifted control ownership into the FloQast platform, replacing a spreadsheet based risk and control matrix with a fully documented control library and task linked evidence. Explicit outcomes stated by the company included elimination of manual accounting processes, improved month end visibility, enhanced controls and compliance, and more efficient audits, with FloQast becoming integral to daily accounting and statutory close workflows.
IT Decision Makers and Key Stakeholders at Helvetia Biopharma
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Helvetia Biopharma Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Helvetia Biopharma Technographics

Helvetia Biopharma is a Life Sciences organization based in Switzerland, with around 150 employees and annual revenues of $65.0 million.

Helvetia Biopharma operates a diverse technology stack with applications such as Microsoft Dynamics 365 for Finance and Operations and FloQast Accounting Automation Platform, covering areas like ERP Financial and Financial Consolidation and Close.

Helvetia Biopharma has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft and FloQast.

Helvetia Biopharma recently adopted applications including Microsoft Dynamics 365 for Finance and Operations in 2025 and FloQast Accounting Automation Platform in 2025, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Helvetia Biopharma’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Helvetia Biopharma’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Helvetia Biopharma technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.